Skip to main content
Premium Trial:

Request an Annual Quote

Orchid, Struggling to Escape Delisting, Plans to Appeal Nasdaq Decision

NEW YORK, Jan. 13-Orchid Biosciences has received a delisting warning notice from Nasdaq, the company said today.

 

Orchid's stock has traded below $1.00 since Sept. 3, which means it is in violation of the rules for continued listing on the exchange.

 

Orchid plans to request a hearing regarding the decision, and its stock will continue to be traded pending the outcome of that hearing.

 

The company is considering a reverse stock split, pending shareholder approval.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.